Video Channel of China Chengdu Mechan Electronic Technology Co., Ltd
Plaudern Kontaktieren Sie uns
Heim Videos Playlist Website

Flächen und Flächen

Weitere Videos
May 30, 2025
Category Connection: Sonden-chirurgisches Instrument
Plaudern Kontaktieren Sie uns
Tags:
#medizinisches chirurgisches Instrument #chirurgische Wegwerfinstrumente #gemeinsame Sonde
Brief: Discover the PLA204 Plasma Technology Urological Surgery Electrode, designed for precise ablation, cutting, and hemostasis with minimal thermal damage. Ideal for urology procedures, this advanced tool ensures efficient tissue removal and bipolar coagulation for superior surgical outcomes.
Related Product Features:
  • Precise tissue removal with controlled plasma field at low temperatures (40°C to 70°C).
  • Minimale thermische Schädigung der umliegenden Gewebe (≤50 μm Verletzungstiefe).
  • Efficient bipolar coagulation for hemostasis without carbonization.
  • Suitable for continuous vaporization and larger bleeding point hemostasis.
  • Easy setup and operation for seamless surgical integration.
  • Reduces risks of urethral sphincter injury and postoperative complications.
  • Enables almost bloodless resection, ideal for large gland operations.
  • Shortens postoperative recovery time and hospital stays.
Häufig gestellte Fragen:
  • What makes the PLA204 Plasma Technology Electrode different from conventional electrosurgical devices?
    The PLA204 uses a controlled plasma field at low temperatures (40°C to 70°C), minimizing thermal damage (≤50 μm) compared to conventional devices (250°C to 350°C and 2200 μm injury depth). It ensures gentle tissue removal without charring or burning.
  • What are the key advantages of using this electrode for benign prostatic hyperplasia treatment?
    The PLA204 allows almost bloodless resection, reduces re-hyperplasia risks, avoids accidental sphincter injury, and shortens recovery time. It also prevents complications like hyponatremia and water intoxication.
  • Wie profitiert die Behandlung von Blasenkrebs von PLA204?
    Es bietet eine minimal-invasive Behandlung von oberflächlichem Blasenkrebs (über 90% Erfolgsquote) und eine Blasen-konservierende Therapie für invasiven Krebs mit Wirkungen, die mit einer offenen Operation vergleichbar sind.
Verwandte Videos